检索

标题
作者
Long-term dynamics of epidemiological characteristics of some chronic leukemia and lymphoma in Moscow before, during and after the pandemic of the new coronavirus infection COVID-19. Epidemiologic study
Vinogradova O., Chernikov M., Neverova A., Kosenkova V., Kochkareva Y., Shikhbabaeva D., Pankrashkina M., Sharkunov N., Ptushkin V.
An interdisciplinary approach to the management of oncohematological patients with immunodeficiency: clinical cases. A review
Babicheva L., Luntsov A., Khusainova G., Poddubnaya I.
Innovations in the therapy of oncohematological diseases
Editorial B.
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study
Korkina Y., Valiev T.
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy
Editorial B.
Pharmacoeconomic analysis of acalabrutinib in patients with chronic lymphocytic leukemia
Nedogoda S., Salasyuk A., Barykina I., Lutova V., Popova E.
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E., Bialik T., Zaritskii A., Iseber L., Kaplanov K., Lopatkina T., Lugovskaia S., Mukhortova O., Osmanov E., Poddubnaya I., Samoilova O., Stadnik E., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience
Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.
Maintenance oncohematological patients and new coronavirus infection: experience of the City Clinical Hospital №52
Baryakh E., Kochneva O., Misyurina E., Zhelnova E., Yatskov K., Zagrebneva A., Zyangirov R., Samsonova I., Poteshkina N., Lysenko M., Poddubnaya I.
Regulatory T-cells (Treg) in lymphoproliferative diseases
Kuzmina E., Mushkarina T., Konstantinova T.
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Al-Radi L., Byalik T., Kaplanov K., Molostvova V., Nikitin E., Pospelova T., Ptushkin V., Samoilova O., Stadnik E., Tumyan G.
Prospective analysis of efficacy and safety of BR regime in the first-line treatment of chronic lymphocytic leukemia
Stadnik E., Strugov V., Andreeva T., Virts Y., Mirolyubova Y., Butylin P., Zaritskiy A.
Hairy cell leukemia. Clinical recommendations
Al’-Radi L., Baikov V., Kovrigina A., Krivolapov I., Moiseeva T., Nikitin E., Pivnik A., Stadnik E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
Current treatment of chronic lymphocytic leukemia. New opportunities and new difficulties
Samoylova O.
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
Bialik T., Vorob'ev V., Ionin V., Ysebaert L., Kaplanov K., Mendeleeva L., Nikitin E., Ptushkin V., Samoilova O., Stadnik E.
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.
Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence
Petrenko A., Kislova M., Dmitrieva E., Nikitin E.
Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children
Shervashidze M., Valiev T., Batmanova N., Tupitsyn N., Serebryakova I.
Detection and monitoring of minimal residual disease in acute megakaryoblastic leukemia in children
Palladina A., Popa A., Valiev T., Nikitaev V., Chernysheva O., Kupryshina N., Serebryakova I., Shvedova T., Kondratchik K., Tupitsyn N.
Possibilities of epigenetic therapy of acute myeloid leukemias in children
Seregin G., Lifshits A., Аleskerova G., Valiev T.
Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses
Valiev T., Korkina Y.
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
Mirolyubova Y., Stadnik E.
1 - 22 的 22 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##